AUSTIN, Texas — Editor's note: The video attached is related to a similar story published in October 2018.

The Cancer Prevention & Research Institute of Texas (CPRIT) collectively awarded professors at the University of Texas from the College of Natural Sciences, Dell Medical School and the Cockrell School of Engineering almost $5 million.

Chemistry professor Jennifer Brodbelt received $3.7 million in funding to create an imaging facility that will help cancer researchers more closely study tissues and cells. The facility will incorporate techniques to image and characterize biological samples in greater molecular detail. 

Brodbelt is partnering with two other leaders in the field – assistant chemistry professor Livia Eberlin and proteomics facility director Maria Person – to create the facility. A space for the new imaging equipment has not been chosen.

Close to $1 million of the CPRIT funding is dedicated to outreach, prevention and screening efforts spearheaded by Michael Pignone at Dell Medical School. Pignone’s outreach efforts will encourage smoking cessation and lung cancer screening in vulnerable adult patients.

RELATED:

 Kids interact with science at UT Health using their brains - literally!

 This UT grad could be the first woman on the moon

 MD Anderson Cancer Center in Smithville plans move to Houston

A similar grant from CPRIT in 2018 allowed Dell Medical School to pilot a program that increased colorectal cancer screenings among CommUnityCare patients from 18% to 37%.

“Our goal is to fill a significant gap in cancer prevention across Central Texas, especially among people facing financial and access barriers to these critical preventive services,” Pignone, chair of Dell Med’s Department of Internal Medicine, said in 2018. “A big part of this effort also involves raising community awareness so that eventually, everyone who needs screening receives it.”

Jennifer Maynard, a chemical engineering professor who specializes in biotechnology and immunology, also received $200,000 in funding for her research in pediatric brain cancer. The funds will help Maynard develop nanosized immunotherapies to treat medulloblastoma, a tumor located in the part of the brain that controls balance and coordination. Medulloblastoma accounts for almost 20% of pediatric brain tumors and occurs most frequently in children between the ages of three and eight.

This year, CPRIT awarded 71 grants to researchers across the state, totaling $136 million.

WATCH: UT professor making breakthroughs in science

PEOPLE ARE ALSO READING:

Stevie Ray Vaughan's legacy lives on in Austin

'You left my baby': Mom wants justice for her 4-year-old son

United Airlines crew, passengers show kindness to boy with autism who had mid-flight meltdown